BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Harvard Business School
Daiichi Sankyo
Farmers Insurance

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206404

« Back to Dashboard

NDA 206404 describes PENTOBARBITAL SODIUM, which is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Custopharm Inc, Elkins Sinn, and Sagent Pharms, and is included in eight NDAs. It is available from one supplier. Additional details are available on the PENTOBARBITAL SODIUM profile page.

The generic ingredient in PENTOBARBITAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Summary for 206404
Applicant:Sagent Pharms
Ingredient:pentobarbital sodium
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 206404
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 206404 ANDA Sagent Pharmaceuticals 25021-676 25021-676-20 1 VIAL in 1 CARTON (25021-676-20) > 20 mL in 1 VIAL
PENTOBARBITAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 206404 ANDA Sagent Pharmaceuticals 25021-676 25021-676-50 1 VIAL in 1 CARTON (25021-676-50) > 50 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:May 23, 2016TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
US Department of Justice
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.